Case Studies
Rare Disease Drug Development: Critical Documents, Patents and Policies
The case study reveals that strategic grant programs, patent incentives and regulatory frameworks have successfully transformed rare disease research from a neglected area into a thriving $200+ billion global market.


The COVID-19 Pandemic of 2020
The COVID-19 pandemic, which began in late 2019, rapidly became a global crisis by early 2020. It overwhelmed healthcare systems, halted economies and reshaped daily life around the world. Countries responded with lockdowns, mask mandates and travel restrictions, while scientists raced to develop vaccines. Despite the immense challenges, global cooperation led to the rollout of the first vaccines by the end of 2020. This case study explores the spread, impacts and response strategies during the first year of the pandemic.
Breast Cancer Treatment – Awareness, Impact, Precaution and Measures
Breast cancer remains the most prevalent cancer among women globally. Over the past decade, significant strides have been made in understanding, diagnosing, and treating this complex disease, leading to improved patient outcomes and personalized care.
AI and Big Data in Healthcare
AI and Big Data are transforming healthcare by enabling faster, more accurate diagnoses, personalized treatment plans and improved patient outcomes. Through advanced data analytics and machine learning, healthcare providers can detect diseases early, predict patient risks and optimize clinical workflows. These technologies also support better resource management and drive cost-efficiency across hospital systems. As AI continues to evolve, it is playing a critical role in shifting healthcare from reactive to proactive and preventive care.